ΑΙ TAKES INDIAN PHARMA REINS

The Indian pharmaceutical sector, one of the largest in the world, is undergoing a strategic transformation in the way it operates. As artificial intelligence (AI) gains prominence across the industry, companies are actively adopting Al-driven solutions to enhance efficiency across the entire pharmaceutical ecosystem. Organisations are investing in AI training programmes to keep their workforce future-ready, foster innovation, strengthen supply chains, and transition away from manual record-keeping. In this industry analysis, experts share their perspectives on how AI is shaping the future of the pharma sector.

- Sanjiv Das

AI may be the buzzword of the moment, but in reality it represents a structural shift rather than a standalone technology. It is emerging as an enabling layer across the pharmaceutical value chain from drug discovery and clinical development to manufacturing and patient engagement.

While AI is widely touted as transformative for the pharma industry, its adoption is not without caveats. There are several ifs and buts around data quality, regulatory expectations, integration with legacy systems, talent readiness, validation standards, and cultural acceptance. The promise is significant, but real impact will depend on how thoughtfully and responsibly the technology is implemented.

On the sidelines of three big events related to the pharma sector recently viz, AI India Impact Summit in New Delhi, BioAsia 2026 in Hyderabad and IPA Summit in Mumbai, pharma stalwarts all agreed to one fact that embracing AI is the only option as it will not only help the sector rise to newer heights but also make people gain more knowledge and work faster.

However, a few experts gave a worrying outlook where questions on the job at stake lingered.

While concerns around employment continue to surface in industry discussions, the broader consensus among experts is that AI adoption is no longer optional. Beyond the headlines and speculation, the real driver for adoption lies in the tangible advantages AI offers across research, development, regulatory processes, and manufacturing operations. Understanding why companies are investing heavily in AI provides greater clarity on the sector's long-term strategic direction.

Why leverage Al?

AI has a huge role to play in the pharma industry.

Ranging from drug discovery, a formulation scientist's assistant, a manufacturing optimiser, a clinical trial accelerator, a regulatory tool, a safety surveillance system etc, AI is being touted as a game changer for the pharma sector.